IIGD - Invesco Investment Grade Defensive ETF
Stock Price: $26.67 USD
0.00 (0.00%)
Updated Apr 21, 2021 4:00 PM EDT - Market closed
Assets | $96.01M |
NAV | $26.67 |
Expense Ratio | 0.13% |
PE Ratio | n/a |
Beta (5Y) | 0.06 |
Dividend (ttm) | $0.79 |
Dividend Yield | 2.97% |
Ex-Dividend Date | Apr 19, 2021 |
1-Year Return | - |
Trading Day | April 21 |
Last Price | $26.67 |
Previous Close | $26.67 |
Change ($) | 0.00 |
Change (%) | 0.00% |
Day's Open | 26.67 |
Day's Range | 26.65 - 26.67 |
Day's Volume | 13,619 |
52-Week Range | 25.97 - 26.95 |
Fund Description
The investment seeks to track the investment results (before fees and expenses) of the Invesco Investment Grade Defensive Index (the underlying index). The fund generally will invest at least 80% of its total assets in securities that comprise the underlying index. The underlying index is designed to provide exposure to U.S. investment grade bonds having the highest quality scores (within the eligible universe of U.S. investment grade bonds) as determined by the index provider. The fund is non-diversified.
Asset Class Fixed Income | Inception Date Jul 25, 2018 |
Exchange NYSEARCA | Ticker Symbol IIGD |
Index Tracked Invesco Investment Grade Defensive Index |
Top 10 Holdings
8.52% of assetsName | Symbol | Weight |
---|---|---|
Massmutual Global Funding II 0.85% | n/a | 0.90% |
Wells Fargo Bank, National Association 3.55% | n/a | 0.90% |
Caterpillar Inc 3.4% | n/a | 0.89% |
CME Group Inc. 3% | n/a | 0.85% |
MetLife Inc. 4.37% | n/a | 0.84% |
Nuveen LLC 4% | n/a | 0.84% |
ConocoPhillips Company 4.95% | n/a | 0.84% |
The Charles Schwab Corporation 0.9% | n/a | 0.83% |
Fifth Third Bank of Cincinnati 3.95% | n/a | 0.82% |
Biogen Inc 4.05% | n/a | 0.82% |
Dividends
Ex-Dividend | Amount | Pay Date |
---|---|---|
Apr 19, 2021 | $0.026 | Apr 30, 2021 |
Mar 22, 2021 | $0.027 | Mar 31, 2021 |
Feb 22, 2021 | $0.025 | Feb 26, 2021 |
Jan 19, 2021 | $0.029 | Jan 29, 2021 |
Dec 21, 2020 | $0.433 | Dec 31, 2020 |
Nov 23, 2020 | $0.031 | Nov 30, 2020 |
News
With a potential vaccine ready for the masses in the United States, there seems to be less uncertainty in the capital markets despite the marked increase in COVID-19 cases. But you can never get too muc...